ATYPICAL THROMBOTIC AND SEPTIC COMPLICATIONS OF TOTALLY IMPLANTABLE VENOUS ACCESS DEVICES IN PATIENTS WITH CYSTIC-FIBROSIS

被引:35
作者
SOLA, JE [1 ]
STONE, MM [1 ]
WISE, B [1 ]
COLOMBANI, PM [1 ]
机构
[1] JOHNS HOPKINS UNIV,DIV PEDIAT SURG,BALTIMORE,MD 21218
关键词
SUPERIOR VENA CAVAL SYNDROME; DEEP VENOUS THROMBOSIS; PULMONARY EMBOLI; PSEUDOMONAS; KLEBSIELLA; FUNGAL SEPSIS;
D O I
10.1002/ppul.1950140407
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The use of vascular access systems in patients with cystic fibrosis (CF) is well accepted, with lower overall complications and maintenance costs than percutaneous silastic catheters. We report our 6 year experience with 22 infusaports in 15 CF patients. Our patients had indwelling catheters for an average of 539 days per catheter (range, 14-2,224 days). These infusaports were used for home antibiotic therapy, blood sampling, and total parenteral nutrition. The overall complication rate was relatively low, 1 in every 1,483 catheter days. Infectious complications were extremely infrequent at a rate of 1 in 5,929 catheter days. The rate of mechanical complications was 1 in 1,976 catheter days. However, superior vena caval syndrome or deep venous thrombosis was associated with 3 of 22 catheters (13.6%). Due to this high incidence of major thrombotic events with the attendant risk of pulmonary embolism, all patients with CF using infusaports and without evidence of liver disease or bleeding problems receive aspirin prophylaxis.
引用
收藏
页码:239 / 242
页数:4
相关论文
共 9 条
[1]   LONG-TERM VENOUS ACCESS USING A TOTALLY IMPLANTABLE DRUG DELIVERY SYSTEM IN PATIENTS WITH CYSTIC-FIBROSIS AND BRONCHIECTASIS [J].
BALL, ABS ;
DUNCAN, FR ;
FOSTER, FJ ;
DAVIDSON, TI ;
WATKINS, RM ;
HODSON, ME .
RESPIRATORY MEDICINE, 1989, 83 (05) :429-431
[2]   THE PATHOLOGY OF FUNGAL INFECTION AND COLONIZATION IN PATIENTS WITH CYSTIC-FIBROSIS [J].
BHARGAVA, V ;
TOMASHEFSKI, JF ;
STERN, RC ;
ABRAMOWSKY, CR .
HUMAN PATHOLOGY, 1989, 20 (10) :977-986
[3]   TOTALLY IMPLANTABLE SYSTEM FOR VENOUS ACCESS IN CHILDREN WITH CYSTIC-FIBROSIS [J].
CASSEY, J ;
FORD, WDA ;
OBRIEN, L ;
MARTIN, AJ .
CLINICAL PEDIATRICS, 1988, 27 (02) :91-95
[4]   BACTEREMIA AND FUNGEMIA IN ADULTS WITH CYSTIC-FIBROSIS [J].
FAHY, JV ;
KEOGHAN, MT ;
CRUMMY, EJ ;
FITZGERALD, MX .
JOURNAL OF INFECTION, 1991, 22 (03) :241-245
[5]   A TOTALLY IMPLANTABLE VENOUS ACCESS SYSTEM FOR LONG-TERM CHEMOTHERAPY IN CHILDREN [J].
MCGOVERN, B ;
SOLENBERGER, R ;
REED, K .
JOURNAL OF PEDIATRIC SURGERY, 1985, 20 (06) :725-727
[6]   TOTALLY IMPLANTABLE VASCULAR ACCESS DEVICES IN CYSTIC-FIBROSIS - A 4-YEAR EXPERIENCE WITH 58 PATIENTS [J].
MORRIS, JB ;
OCCHIONERO, ME ;
GAUDERER, MWL ;
STERN, RC ;
DOERSHUK, CF .
JOURNAL OF PEDIATRICS, 1990, 117 (01) :82-85
[7]  
ROSS MN, 1988, SURG GYNECOL OBSTET, V167, P141
[8]   USE OF A TOTALLY IMPLANTABLE SYSTEM FOR VENOUS ACCESS IN CYSTIC-FIBROSIS [J].
STEAD, RJ ;
DAVIDSON, TI ;
DUNCAN, FR ;
HODSON, ME ;
BATTEN, JC .
THORAX, 1987, 42 (02) :149-150
[9]   SILASTIC CATHETERS FOR ANTIBIOTICS IN CYSTIC-FIBROSIS [J].
WILLIAMS, J ;
SMITH, HL ;
WOODS, CG ;
WELLER, PH .
ARCHIVES OF DISEASE IN CHILDHOOD, 1988, 63 (06) :658-659